The Evolution of Cell and Gene Therapy Processing Tools
01/ Borrowed tools from other industries Prior to the invention of gene therapy research, the removal, storage and reinsertion of human cell tissue was limited to blood. The logistical and technical challenges were minimal. However, scientists quickly discovered that maintaining the integrity and transparency of autologous and allogeneic cells throughout extraction, storage, transportation, delivery and […]
Not All Sustainability Efforts Are Created Equal: What should be considered outside ENERGY STAR® when trying to conserve energy in your laboratory?
We are pleased to see the progress research organizations are making toward reducing climate impact while increasing energy efficiency, but with an energy crisis looming, it may be time to take a step back and look at the sustainability measures currently in place within your laboratory, and re-evaluate which tactics will have the greatest impact. […]
Sexton Biotechnologies to be Acquired by Biolife Solutions
Sexton Biotechnologies, a provider of novel manufacturing solutions for the cell and gene therapy (CGT) industry, today announced that it has entered into a definitive agreement whereby BioLife Solutions (NASDAQ: BLFS) will acquire all outstanding shares of the company in a deal worth a total value of $30 million. During the past two years, Sexton has worked to provide […]
Reducing Total Cost of Ownership When Upgrading ULT Freezers Can Reap Savings and Fund Additional Research
Learn how to collaborate with different departments in your organization to demonstrate the total cost of operation and realize the savings when it’s time to upgrade your ULT freezers to newer, high-efficiency models.
The Number of FDA-Approved Autologous CAR T Cell Therapies Continues to Grow
Bristol Myers Squibb’s Breyanzi Receives FDA Approval. Breyanzi is Cryopreserved in CryoStor® CS10. Earlier this year, the U.S. Food and Drug Administration published a press release announcing the approval of CD19-targeting CAR T cell therapy, Breyanzi (lisocabtagene maraleucel; liso-cel). Breyanzi is approved to treat adult patients with relapsed or refractory large B-cell lymphoma that has not responded following “two or more […]
Health Europa Highlights the Critical Need for a Global Ultracold Infrastructure
Issued quarterly by independent publisher, Pan European Networks Ltd, Health Europa is a digital publication that reports on the latest trends and developments in health and healthcare from across Europe and beyond. The publication regularly includes coverage of research, innovation, health policy and new technologies. Health Europa’s latest Spring issue focuses on the fast-growing worlds […]